Clinical Trials Logo

In-stent Arterial Restenosis clinical trials

View clinical trials related to In-stent Arterial Restenosis.

Filter by:
  • None
  • Page 1

NCT ID: NCT04365062 Recruiting - Clinical trials for Atherosclerosis of Artery

Clinical Study of Excimer Laser and Drug Coated Balloon Versus Excimer Laser and Plain Balloon Versus Plain Balloon and Drug Coated Balloon to Treat Femoropopliteal In-stent Restenosis

Excellent
Start date: January 1, 2018
Phase: N/A
Study type: Interventional

This is a randomized study comparing Excimer laser and drug coated balloon Versus Excimer laser and plain balloon versus plain balloon and drug coated balloon to Treat femoropopliteal in-stent restenosis

NCT ID: NCT02832024 Recruiting - Atherosclerosis Clinical Trials

Clinical Study of Stent Versus Direct Atherectomy Versus Angioplasty to Treat Lower Limb In-stent Restenosis

Start date: January 2016
Phase: N/A
Study type: Interventional

This is a randomized study comparing Stent Versus Direct Atherectomy Versus Angioplasty to Treat Lower Limb In-stent Restenosis (superficial femoral or popliteal artery).

NCT ID: NCT01616888 Active, not recruiting - Clinical trials for In-stent Arterial Restenosis

Paclitaxel Eluting Balloon for SFA In-stent Restenosis

Start date: June 2012
Phase: N/A
Study type: Interventional

The purpose of the study is to evaluate the safety and efficacy on the use of drug eluting balloon (DEB) with paclitaxel to treat in-stent restenosis in femoropopliteal arteries.

NCT ID: NCT01495533 Completed - Clinical trials for In-stent Arterial Restenosis

Paclitaxel-coated or Uncoated AngioSculpt Scoring Balloon Catheter

Start date: December 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to examine the treatment of coronary Bare Metal Stent restenosis with a drug coated AngioSculpt scoring balloon.

NCT ID: NCT01365572 Recruiting - Clinical trials for In-stent Arterial Restenosis

New Generation Drug Eluting Stent for In-stent Restenosis of Drug Eluting Stent( RESTENT-ISR Trial )

Restenosis
Start date: January 2010
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the feasibility, safety, and effectiveness of EndeavorTM ResoluteTM and Xience VTM stent implantation in patients with restenosis following drug-eluting stent (DES) implantation. The investigators will evaluate clinical, angiographic and intravascular ultrasound (IVUS) assessment of 9-month efficacy of EndeavorTM ResoluteTM or Xience VTM implantation in DES restenosis and assess the vascular changes of re-treatment with DES for DES restenosis using follow-up IVUS analysis. In addition, the investigators will evaluate the effectiveness of retreatment with EndeavorTM ResoluteTM or Xience VTM stent implantation in patients with restenosis after DES